BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 2860516)

  • 1. Adverse reactions associated with pyrimethamine-sulfadoxine prophylaxis for Pneumocystis carinii infections in AIDS.
    Navin TR; Miller KD; Satriale RF; Lobel HO
    Lancet; 1985 Jun; 1(8441):1332. PubMed ID: 2860516
    [No Abstract]   [Full Text] [Related]  

  • 2. Fatal toxic epidermal necrolysis during prophylaxis with pyrimethamine and sulfadoxine in a human immunodeficiency virus-infected person.
    Raviglione MC; Dinan WA; Pablos-Mendez A; Palagiano A; Sabatini MT
    Arch Intern Med; 1988 Dec; 148(12):2683-5. PubMed ID: 3264143
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Use of pyrimethamine-sulfadoxine (Fansidar) in prophylaxis against chloroquine-resistant Plasmodium falciparum and Pneumocystis carinii.
    Pearson RD; Hewlett EL
    Ann Intern Med; 1987 May; 106(5):714-8. PubMed ID: 3551713
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Leads from the MMWR. Fansidar-associated fatal reaction in an HIV-infected man.
    JAMA; 1988 Oct; 260(15):2193. PubMed ID: 3262778
    [No Abstract]   [Full Text] [Related]  

  • 5. The safety of pyrimethamine and sulfadoxine for the prevention of Pneumocystis carinii pneumonia.
    Teira R; Virosta M; Muñoz J; Zubero Z; Santamaría JM
    Scand J Infect Dis; 1997; 29(6):595-6. PubMed ID: 9580544
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Stevens-Johnson syndrome and granulopenia induced by sulfadoxine-pyrimethamine (Fansidar)].
    Ligthelm RJ; van Zwienen J; Stuiver PC; Djajadiningrat AP
    Ned Tijdschr Geneeskd; 1983 Sep; 127(38):1735-7. PubMed ID: 6633717
    [No Abstract]   [Full Text] [Related]  

  • 7. Prophylaxis of Pneumocystis carinii infection in AIDS with pyrimethamine-sulfadoxine.
    Gottlieb MS; Knight S; Mitsuyasu R; Weisman J; Roth M; Young LS
    Lancet; 1984 Aug; 2(8399):398-9. PubMed ID: 6147471
    [No Abstract]   [Full Text] [Related]  

  • 8. Adverse reactions to sulphadoxine-pyrimethamine in Swedish travellers: implications for prophylaxis.
    Hellgren U; Rombo L; Berg B; Carlson J; Wiholm BE
    Br Med J (Clin Res Ed); 1987 Aug; 295(6594):365-6. PubMed ID: 2958104
    [No Abstract]   [Full Text] [Related]  

  • 9. Stevens-Johnson syndrome due to pyrimethamine/sulfadoxine during presumptive self-therapy of malaria.
    Phillips-Howard PA; Behrens RH; Dunlop J
    Lancet; 1989 Sep; 2(8666):803-4. PubMed ID: 2571042
    [No Abstract]   [Full Text] [Related]  

  • 10. Severe cutaneous adverse reactions and sulphadoxine-pyrimethamine in Sabah, Malaysia.
    Lyn PC; Fernandez E
    Med J Aust; 1987 Mar; 146(6):335-6. PubMed ID: 2950306
    [No Abstract]   [Full Text] [Related]  

  • 11. Erythema multiforme (Stevens-Johnson) precipitated by Fansidar.
    Adams SJ; Broadbent J; Clayden LM; Ridley CM
    Postgrad Med J; 1985 Mar; 61(713):263-4. PubMed ID: 3983064
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Fansidar-induced Stevens-Johnson Syndrome.
    Hornstein OP; Ruprecht KW
    N Engl J Med; 1982 Dec; 307(24):1529-30. PubMed ID: 7144829
    [No Abstract]   [Full Text] [Related]  

  • 13. [Malaria prevention with Fansidar as a cause of Stevens-Johnson syndrome].
    Claréus BW; Hammar H
    Lakartidningen; 1985 Nov; 82(48):4211. PubMed ID: 4079604
    [No Abstract]   [Full Text] [Related]  

  • 14. Fatal Stevens-Johnson syndrome associated with Fansidar and chloroquine.
    Bamber MG; Elder AT; Gray JA; Minns RA
    J Infect; 1986 Jul; 13(1):31-3. PubMed ID: 3734464
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Fatal Stevens-Johnson syndrome associated with Fansidar and chloroquine.
    Lenox-Smith I
    J Infect; 1987 Jan; 14(1):90-2. PubMed ID: 3819463
    [No Abstract]   [Full Text] [Related]  

  • 16. Serious reactions during malaria prophylaxis with pyrimethamine-sulfadoxine.
    Olsen VV; Loft S; Christensen KD
    Lancet; 1982 Oct; 2(8305):994. PubMed ID: 6127497
    [No Abstract]   [Full Text] [Related]  

  • 17. Three cases of acquired immunodeficiency syndrome complicated with toxic epidermal necrolysis.
    Kimura S; Oka S; Mohri H; Mitamura K; Shimada K
    Jpn J Med; 1991; 30(6):553-8. PubMed ID: 1798215
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Is the use of Fansidar as an antimalarial justified?].
    Olsen VV
    Ugeskr Laeger; 1985 Feb; 147(7):624-5. PubMed ID: 3976083
    [No Abstract]   [Full Text] [Related]  

  • 19. An unusual combination of phototoxicity and Stevens-Johnson syndrome due to antimalarial therapy.
    Ortel B; Sivayathorn A; Hönigsmann H
    Dermatologica; 1989; 178(1):39-42. PubMed ID: 2917679
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Stevens-Johnson syndrome in a patient treated with quinine and pyrimethamine-sulfadoxine].
    Gascón Brustenga J; Merlos Pujol A; Bada Ainsa JL
    Med Clin (Barc); 1986 Dec; 87(19):821-2. PubMed ID: 3821238
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.